celeste-gott documents

Phase II Trial of Trastuzumab Followed by Weekly Paclitaxel/Carboplatin as First-Line Treatment for Patients with Metastatic Breast Cancer Burris H III,
Documents Phase II Trial of Trastuzumab Followed by Weekly Paclitaxel/Carboplatin as First-Line Treatment for Patients with Metastatic Breast Cancer Burris H III,